Sponsor Pipeline

Shanghai Argo Biopharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
3
Recruiting
Active Trials by Phase
Phase 2
3
Phase 1
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06497127 A Study in Patients With Mixed Dyslipidemia Mixed Dyslipidemia Active, Not Recruiting
NCT07135349 A Phase II Clinical Study of BW-20507 in Combination With PEG-IFNα for the Treatment of… Chronic Hepatitis B Active, Not Recruiting
NCT06846398 A Phase 2 in Adult Subjects With Hereditary Angioedema Hereditary Angioedema (HAE) Active, Not Recruiting
Phase 1
NCT06917482 A Study to Assess the Safety and Effects of the Investigational Drug BW-40202 in Healthy… Healthy Volunteers Only Recruiting
NCT07401472 Study of BW-50218 in Healthy Participants Healthy Participants Study Recruiting
NCT07584876 A Phase 1 Clinical Study in Healthy Participants HV Recruiting
NCT07528053 A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants HV Not Yet Recruiting
NCT07577479 A Phase 1 Study of Single-Dose BW-50218 in Healthy Chinese Participants Healthy Participants Study Active, Not Recruiting
Get alerts when Shanghai Argo Biopharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free